PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20145144-0	2010	Sensitivity and acquired resistance of BRCA1;p53-deficient mouse mammary tumors to the topoisomerase I inhibitor topotecan.	Topotecan	113-122	breast cancer 1, early onset	Mus musculus	39-44	
23028879-2	2012	Using our conditional K14cre;Brca1(F/F);p53(F/F) mouse model, we showed previously that BRCA1;p53-deficient mammary tumors initially respond to topotecan, but frequently acquire resistance by overexpression of the efflux transporter ABCG2.	Topotecan	144-153	breast cancer 1, early onset	Mus musculus	88-93